- ExchangeLondon Stock Exchange
- SectorHealth Care Equipment & Services
- CountryUnited Kingdom
A director at ConvaTec Group maiden bought 25,000 shares at 160p and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of b...
The general evaluation of CONVATEC GROUP PLC. (GB), a company active in the Pharmaceuticals industry, has been upgraded by the independent financial analyst theScreener with the addition of a star. Its fundamental valuation now shows 4 out of 4 possible stars while its market behaviour can be considered as defensive. theScreener believes that the additional star(s) merits the upgrade of its general evaluation to Positive. As of the analysis date February 7, 2020, the closing price was GBp 212.30 and its potential was estimated at GBp 240.86.
Summary Marketline's Anglo American Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Anglo American Plc since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. ...
Feasibility Study Results in December to be a Catalyst for this Junior
Narrow-moat ConvaTec posted first-quarter revenue results that were consistent with our measured expectations, and we’re holding steady on our fair value estimate. Quarterly organic revenue growth was down 2% year over year, reflecting weakness in advanced wound care and ostomy. In the past, we’ve described ConvaTec as a dumpster fire, and we now think it resembles more of a smoldering fire. Interim management has laid out a series of tactical plans to establish more strategic marketing, including the use of specialist sales reps and more clinical data to support its Aquacel wound care franchi...
La tendance est baissière. Les prix baissent à nouveau, mais le mouvement est devenu hésitant. Le prochain support est à 189,08 p. La tendance baissière serait remise en cause au-dessus de 237,60 p.
La tendance est haussière. La baisse récente gagne en vigueur. Le prochain support est à 179,14 p. La tendance serait remise en cause par la rupture de 179,14 p.
The trend is bearish. Prices are falling again, but the movement has become hesitant. The next support is at 189.08 p. The bearish trend would be challenged above 237.60 p.